
GSK vs PBYI
$GSK vs $PBYI head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs PBYI: the quick read
- ·GSK is the larger company by market cap ($94.14B vs $515M).
- ·GSK has been more active on our scanner (62 vs 21 alerts in 30 days).
- ·PBYI has the smaller float (39.1M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·PBYI trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 62 and 21 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: GSK is more than 183x the market cap of PBYI, so the same dollar of news moves PBYI far harder.
- ·They have diverged badly over the year: PBYI is near the top of its 52-week range while GSK is near the bottom of its own.
- ·GSK pays a dividend and PBYI does not, which usually means one is being held for income and the other for the move.
- ·GSK is the one in play today, trading about 2.2x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and PBYI on TheDesperateTrader.
- Is GSK or PBYI the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($94.14B vs $515M). GSK has been more active on our scanner (62 vs 21 alerts in 30 days). PBYI has the smaller float (39.1M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and PBYI?
- The differences that matter: GSK is roughly 183x the size of the other by market cap ($94.14B vs $515M); they trade at very different share prices ($46.51 vs $9.97); GSK sits at 19% of its 52-week range against 98% for PBYI; only GSK pays a dividend; our scanner flagged GSK 62 times in the last 30 days against 21 for PBYI. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and PBYI is more active right now?
- Right now GSK is at about 2.2x its normal volume and PBYI is at about 1.1x, so GSK is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or PBYI? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.